Risk factors | EBV viremia | EBV-associated diseases | CMV viremia | CMV-associated diseases | ||||
---|---|---|---|---|---|---|---|---|
 | Univariate | Multivariate (RR) | Univariate | Multivariate (RR) | Univariate | Multivariate (RR) | Univariate | Multivariate (RR) |
male vs female | NS | NS | NS | NS | NS | NS | NS | NS |
Age, <20 years vs ≥20 to ≤ 40 years vs > 40 years | NS | NS | NS | NS | NS | NS | NS | NS |
Disease status, CR vs NR | P = 0.029 | NS | NS | NS | NS | NS | NS | NS |
Related vs unrelated donor | P<0.001 | NS | P<0.001 | NS | NS | NS | NS | NS |
HLA typing, matched vs mismatched | P<0.001 | NS | P<0.001 | NS | P<0.001 | P<0.001 (2.441) | NS | NS |
Standard vs intensified conditioning | P = 0.002 | P = 0.037 (1.759) | P = 0.006 | P = 0.037 (2.290) | NS | NS | NS | NS |
EBV serological matches vs mismatches | NS | NS | NS | NS | NS | NS | NS | NS |
CMV serological matches vs mismatches | NS | NS | NS | NS | NS | NS | NS | NS |
ATG vs no ATG | P<0.001 | P<0.001 (15.554) | P<0.001 | P<0.001 (19.216) | P<0.001 | NS | P = 0.006 | NS |
Flu vs no Flu | NS | NS | NS | NS | NS | NS | NS | NS |
Acute GVHD II-IV vs 0-I | NS | NS | P = 0.032 | NS | P<0.001 | NS | P = 0.002 | P = 0.017 (12.554) |
Chronic GVHD vs no cGVHD | NS | NS | NS | NS | NS | NS | NS | NS |
Early CsA withdrawal vs no early withdrawal | NS | NS | NS | NS | P<0.001 | P = 0.002 (2.112) | NS | NS |
DLI vs no DLI | NS | NS | NS | NS | P = 0.010 | NS | NS | NS |